Yes should be a significant uplift on DFS ebitda, can’t get over a potential by product contributing circa 35 per cent of ebitda.
When you say you are hearing about imminent US research reports, who are you hearing from? Also any sense as to when in this quarter BFS will be issued?
Tempted to buy more but am probably way overexposed!!
cheers
-
- There are more pages in this discussion • 1,966 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
52.0¢ |
Change
0.025(5.05%) |
Mkt cap ! $7.645M | |||
| Open | High | Low | Value | Volume |
| 50.0¢ | 52.0¢ | 50.0¢ | $5.103K | 10.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2358 | 50.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 51.5¢ | 6000 | 1 |
View Market Depth
| Last trade - 11.24am 03/07/2025 (20 minute delay) ? |
| 5EA (ASX) Chart |